Enovis Co. (NYSE:ENOV – Get Rating) CEO Matthew L. Trerotola sold 3,945 shares of the stock in a transaction on Thursday, February 23rd. The shares were sold at an average price of $54.62, for a total transaction of $215,475.90. Following the completion of the sale, the chief executive officer now directly owns 162,544 shares of the company’s stock, valued at $8,878,153.28. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Enovis Stock Performance
Shares of ENOV stock opened at $55.81 on Friday. Enovis Co. has a 52-week low of $43.88 and a 52-week high of $128.25. The stock has a market cap of $3.02 billion, a price-to-earnings ratio of 116.27 and a beta of 2.04. The firm has a fifty day moving average of $59.07 and a 200-day moving average of $54.33.
Enovis (NYSE:ENOV – Get Rating) last announced its quarterly earnings data on Thursday, February 23rd. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.03. The company had revenue of $409.00 million during the quarter, compared to analysts’ expectations of $415.79 million. Enovis had a net margin of 0.94% and a return on equity of 4.46%. The business’s revenue was down 60.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.77 EPS. On average, sell-side analysts predict that Enovis Co. will post 2.24 earnings per share for the current year.
Analysts Set New Price Targets
Institutional Investors Weigh In On Enovis
A number of hedge funds have recently made changes to their positions in the company. Natixis acquired a new stake in shares of Enovis during the 4th quarter worth about $1,097,000. Front Street Capital Management Inc. increased its position in shares of Enovis by 2.4% during the 4th quarter. Front Street Capital Management Inc. now owns 176,382 shares of the company’s stock worth $9,440,000 after purchasing an additional 4,184 shares in the last quarter. Teachers Retirement System of The State of Kentucky increased its position in shares of Enovis by 42.1% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 7,762 shares of the company’s stock worth $416,000 after purchasing an additional 2,300 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of Enovis by 0.4% during the 4th quarter. Alliancebernstein L.P. now owns 67,786 shares of the company’s stock worth $3,628,000 after purchasing an additional 279 shares in the last quarter. Finally, State of Wyoming increased its position in shares of Enovis by 59,200.0% during the 4th quarter. State of Wyoming now owns 593 shares of the company’s stock worth $32,000 after purchasing an additional 592 shares in the last quarter. Institutional investors and hedge funds own 96.73% of the company’s stock.
Enovis Company Profile
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries.
Read More
- Get a free copy of the StockNews.com research report on Enovis (ENOV)
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
- Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Receive News & Ratings for Enovis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovis and related companies with MarketBeat.com's FREE daily email newsletter.
